Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03108898 · ClinicalTrials.gov registry record
Progenitor Cells in Human Esophagus
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 10
- Enrollment target
NCT03108898: Completed study, sponsored by Mayo Clinic.
NCT03108898 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03108898 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand how esophageal cells change with age.
Primary Outcome
We will examine sections of different portions of the esophagus, to determine whether certain sections contain more progenitors, and thus perhaps a greater ability to regenerate, than others.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-06-29 |
| Est. Completion | 2022-11-22 |
What the finished NCT03108898 record still lists
NCT03108898 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03108898 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03108898 about?
NCT03108898 is a clinical study titled "Progenitor Cells in Human Esophagus". The purpose of this study is to better understand how esophageal cells change with age.
What is the current status of trial NCT03108898?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2017-06-29. Estimated completion is 2022-11-22.
Who is sponsoring clinical trial NCT03108898?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI